Skip to main content
TSHA logo

TSHA · Taysha Gene Therapies, Inc. · Share Buybacks

Track TSHA — free
$4.25 +0.24 (+5.99%) At close · Oct 27 Q2 2026 earnings call transcript
Market Cap
$1.36B
Shares
325.83M
Volume · Oct 27 2.82M Avg daily vol (3M) 3.55M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Equity Offering (ATM) Programs

Program Established Capacity Remaining Runs Through
2021-10 $212,000,000 — —
Key facts CIK 1806310 CUSIP 877619106 13F (30d) 19 filings 19 filers Visit website Investor relations